238 related articles for article (PubMed ID: 35293586)
21. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
22. Adult centronuclear myopathies: A hospital-based study.
Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
[TBL] [Abstract][Full Text] [Related]
23. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic analysis of a case with centronuclear myopathy caused by SPEG gene mutation: a case report and literature review.
Zhang G; Xu M; Huang T; Lin W; Chen J; Chen W; Chang X
BMC Pediatr; 2021 Apr; 21(1):209. PubMed ID: 33926407
[TBL] [Abstract][Full Text] [Related]
25. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
[TBL] [Abstract][Full Text] [Related]
26. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
[TBL] [Abstract][Full Text] [Related]
27. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
29. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
30. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
[TBL] [Abstract][Full Text] [Related]
33. Myotonia in DNM2-related centronuclear myopathy.
Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
[TBL] [Abstract][Full Text] [Related]
34. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
Fujise K; Noguchi S; Takeda T
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
[TBL] [Abstract][Full Text] [Related]
35. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
36. The myopathy-causing mutation DNM2-S619L leads to defective tubulation in vitro and in developing zebrafish.
Gibbs EM; Davidson AE; Telfer WR; Feldman EL; Dowling JJ
Dis Model Mech; 2014 Jan; 7(1):157-61. PubMed ID: 24135484
[TBL] [Abstract][Full Text] [Related]
37. Novel SPEG variant cause centronuclear myopathy in China.
Tang J; Ma W; Chen Y; Jiang R; Zeng Q; Tan J; Jiang H; Li Q; Zhang VW; Wang J; Tang H; Luo L
J Clin Lab Anal; 2020 Feb; 34(2):e23054. PubMed ID: 31625632
[TBL] [Abstract][Full Text] [Related]
38. Striated Preferentially Expressed Protein Kinase (SPEG) in Muscle Development, Function, and Disease.
Luo S; Rosen SM; Li Q; Agrawal PB
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072258
[TBL] [Abstract][Full Text] [Related]
39. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
40. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
Tinelli E; Pereira JA; Suter U
Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
